Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome.
Am Heart J
; 257: 33-40, 2023 03.
Article
in En
| MEDLINE
| ID: mdl-36435233
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Takotsubo Cardiomyopathy
/
Heart Failure
Type of study:
Clinical_trials
/
Guideline
Limits:
Humans
Language:
En
Journal:
Am Heart J
Year:
2023
Type:
Article